REFERENCES
- Hon Y Y, Evans W E. Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach. Clin Chem 1998; 44: 388–400, [PUBMED], [INFOTRIEVE], [CSA]
- Fuskevåg O, Kristiansen C, Lindal S, Aarbakke J. Maximum tolerated doses of methotrexate and 7-dydroxy-methotrexate in a model af acute toxicity in rats. Cancer Chemother Pharmacol 2000; 46: 69–73, [CSA], [CROSSREF]
- Sandri M T, Cardinale D, Zorzino L, et al. Minonor increases in plasma troponin I predict decreased left ventricular ejection fraction after high-dose chemotherapy. Clin Chem 2003; 49: 248–252, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lawson G J, Dixon P F. Rapid and simple method for the measurement of methotrexate and 7-hydroxymethotrexate in serum by high-performance liquid chromatography. J Chromatogr 1981; 223: 225–231, [PUBMED], [INFOTRIEVE], [CSA]